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Overview of the thesis 
ABSTRACT/SHORT RESEARCH OVERVIEW (NOT EXCEEDING 350 WORDS) 
Introduction 
This study tested the hypothesis that there is no difference in both short-term infection 
rates and late implant sepsis and non-union rates between in HIV positive and HIV 
negative patients treated by reamed, closed femoral nailing for closed femur fractures. 
Patients and Methods 
Between February 2011 and December 2012 all patients with femur shaft fractures 
treated by reamed intramedullary nailing were recruited at a single referral hospital with 
a high rate of trauma and HIV prevalence.  Thirty-two HIV positive patients and 80 HIV 
negative patients were enrolled and followed up clinically. Other variables included high 
or low energy injuries, age, AO/ASIF fracture pattern and CD4 counts. They were assessed 
for wound sepsis using the ASEPSIS method and followed up radiologically to assess for 
union of their nailed femurs. Follow-up was by telephonic interview to assess for late 
implant sepsis and non-union.  
Results 
There were no cases of early implant sepsis in either the 32 HIV positive or 80 HIV negative 
patients noted in the clinical and radiological follow up. Only one patient in the HIV 
positive cohort had a high ASEPSIS score, but this was deemed a superficial infection 
which resolved on antibiotics.  A 3-year telephonic assessment of 32 HIV positive patients 
and 71 HIV negative patients with implants in situ and was undertaken. No cases of sepsis 
were found in the HIV group and one case of sepsis in the HIV positive group and this 
sepsis resolved after nail removal. Interestingly, this was in a patient who was initially HIV 
negative when nailed and later sero-converted.  There were no cases of non-union in the 
HIV positive group or the HIV negative groups at 3 year follow up. 
Conclusions 
This research study found no increased risk of sepsis in closed femoral shaft fractures 
treated by internal fixation in HIV positive patients and adds to the limited literature 
regarding long term implant sepsis in HIV positive patients and concludes that there 
is no apparent increased risk of late, implant sepsis. There does not appear to be an 
increased non-union rate in HIV positive patients treated by reamed nailing fixation 
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Part 1: The Review of Literature 
RESEARCH QUESTION 
Does HIV infection increase the risk of early or late implant sepsis and non-union rate in patients with 
closed femur fractures treated by closed reamed femoral nailing technique? 
LITERATURE REVIEW 
 Introduction 
Human immunodeficiency virus infection affects approximately 40 million people globally (1), with the 
majority of all infections (75.4%) in sub-Saharan Africa. In South Africa, KwaZulu-Natal (KZN) presented a 
unique challenge with the highest HIV infection rate of all the South African provinces (2, 3).  KZN is a large 
province with geographical challenges, with many of the population living in rural regions (4). They have 
poor infrastructure, limited access to health and education and the many of the population survive on 
government grants. This fact firstly makes regular health follow-up difficult for post-operative patients 
and it is difficult for the rural patient to mobilise and rehabilitate, even with assistive devices. Trauma is 
prevalent in KZN and very high traffic loads locally and internationally increase the risk of major injury 
further. (5)  
Basic science of bone healing 
The skeleton is the basic support structure of all vertebrate animals. It is inherently one of the most 
important structures for mobility and functionality. When this framework has been disrupted by fracture, 
either low energy or high energy trauma, paracrine and autocrine intracellular pathways of healing are 
initiated to start the process of repair (6). Bone heals by two processes, primary or secondary bone 
healing. The primary bone healing involves the cutting cone technique and the secondary bone healing 
involves a more nutritionally demanding process with enchondral ossification (6). There are a lot of 
variables that affect this process of healing, importantly nutrition with albumin levels of < 3.5 g/100 ml 
thought to be poor prognostic factor for both bone and wound healing (6, 7). Although HIV was previously 
thought to be a risk factor of poor bone healing, Bates (8) did not find any significant risk in this population 
after clean surgery when compared with HIV negative patients. HIV positive patients may also be on 
multiple drug therapy and this increases the load on the hepatic system which assists in drug metabolism 
including synthesis and maintenance of the nutritional level of the body. Opportunistic co-infection, along 
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with other medical diseases (diabetes, hypertension and tuberculosis) can also complicate the bone 
healing process by increasing the nutritional demand of the patient. This result in low protein reserves 
and poor synthesis and response of both immune mediators and immune cells. 
It is noted that different types of bone respond differently to the process of bone healing. There are other 
variables that also influence this process in orthopaedic surgery. The type of movement at the fracture 
site, the type of bone involved (6), surgical technique, type of fixation and other factors are contributory. 
This will make it difficult comparing different types of bones, with different quality of blood supply and 
different biomechanics, modes of implant fixation for rate of infection and healing process. Even the 
femur, for example, has different healing potential depending on which part is fractured. The proximal 
and distal ends have cancellous bone, compared to the shaft, and the two have different blood supply, 
muscle attachment and healing potential. If one bone in a single patient has different healing potential in 
different areas, this poses a huge challenge for the researcher trying to compare different bones in 
different patients because you may not even get the same results in the same patient. This is a challenge 
which was and still is difficult to resolve in orthopaedic surgery and many more studies to this effect have 
to be performed to better understand this process. This will help us to be pro-active rather than reactive 
in the management of both complex and simple fractures. 
Many more variables have been cited as significant risk factors to non-union and/or sepsis after fractures. 
These include alcohol, NSAID, corticosteroids anaemia (6), poor nutrition (6,7); and also smoking (9,10). 
Many patients in sub-Saharan Africa are from rural poverty-stricken settlements, and this means that food 
security is an additional challenge for fracture healing (9). There may also be a lack of running water and 
proper sanitary facilities. In this type of environment, it becomes a challenge to maintain proper hygiene 
and infection, especially with bone-implants, becomes a significant health risk. (11) 
HIV & AIDS  
Human immunodeficiency virus (HIV) is a reverse transcriptase virus that attacks the immune system 
causing reduction in the CD4+ T cells and chronic inflammatory response (12). Sub-Saharan Africa has the 
greatest HIV prevalence and death rates compared to the rest of the world (13, 14). In South Africa, KZN 
was reported to have the highest number of people living with HIV, compared to the rest of the country 
(15). The prevalence of HIV in this part of South Africa has been estimated to be around 30% (3, 14, 16). 
Since 1994, health education in schools has increased with specific awareness increased in the field of 
teenage pregnancy and sexually transmitted infection, especially HIV. This has seen a steady behavioural 
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change among the youth and young adults, but there is still more to be done. Notable gains have been 
made in the fight against HIV with a decrease in the total death rate (14). These declines can also be partly 
due to the increase in the roll-out of anti-retroviral medication by government and people’s awareness 
through the government run programmes in both schools and communities. Only patients with CD4+ 
count of <350cells/ul previously had access to government issued anti-retroviral treatment, due to the 
government policy at the time that the current study was done. This policy enabled access to anti-
retroviral therapy before reaching AIDS defining stage of CD4+ cells of <200cells/ul. There is currently a 
recently introduced test and treat policy in place fully supported by the government that ensures that all 
persons living with HIV receive treatment, irrespective of CD4+ cell-count. This is the standard-of-care in 
other first world countries and it sustains HIV patients longer in a disease-free physiological condition, 
before presenting with AIDS defining conditions. The point of entry voluntary counselling and testing is 
actively practiced throughout KZN. The risk of opportunistic infection increases greatly if patients are in 
an AIDS defining stage, classified by the WHO as CD4+ cell count of <200cells/ul or AIDS defining 
pathologies. 
HIV infection still carries a stigma in South Africa in general. There are low literacy rates, especially in the 
rural areas where the majority of the population are still more reliant on traditional medication. Health 
care workers do not have any particular influence in convincing the patient population to test, thus the 
state hospital gateway clinics have a policy to counsel and voluntarily test every patient entering the 
health care facility regardless of the illness. Subsequently there is no undue pressure on the patient to 
test and/or uncertainty on whether they will receive treatment if they refuse to test. 
 
HIV and Orthopaedic Surgery 
The unknown HIV status in many of our population raises a particular concern of probable increased risk 
of both infection and non-union of fractures after implant surgery. Also, known HIV positive status raises 
concerns that patient may receive sub-standard operative treatment because of fear of increased risk of 
infection by the treating surgeon. Earlier studies have supported this hypothesis (17, 18) but the more 
recent literature has found no significant increase in risk of implant sepsis and non-union in HIV positive 
patients when compared with HIV negative patients (16, 18-21). These studies compared different bones, 
with multiple operations and different patients. The challenge of different healing potential, operative 
procedures and biomechanics of both implants and bone were not accounted for. 
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Locked Femoral nailing 
The locked femoral nailing technique was developed to improve the outcome of morbidity in femoral 
fractures. In earlier years, femoral fractures were treated by skin traction and plaster of Paris bracing 
which gave very poor results, i.e. malunions and stiff knee (22). The treatment of femoral fractures 
evolved to plate fixation, which in itself, came with more challenges. Sepsis, non-union and mechanical 
failure were some of the more pressing concerns for the orthopaedic surgeon. During the era of Closed 
Küntscher nailing, non-union and infection rate were reduced and function improved. This nailing 
technique did not control rotation and shortening. With the evolving modern transport systems, 
increasing access to automotive vehicles by an increasingly younger population and, more commonly in 
the local environment, high alcohol consumption, high energy injury is becoming more frequent (5). 
Locked femoral nailing techniques are an absolute necessity for early mobilisation, better rehab and early 
return to work. Locked femoral nailing is the standard of care technique for femoral shaft fracture fixation 
in most local units (5). It is a less invasive technique with minimal soft tissue disturbance around the 
fracture site, maintains the length of the patient’s femur and adequately controls the rotation in the axial 
plane. 
Harrison (17) compared different bones with different healing capabilities, while Howard, Aird and Phaff 
(16) and Seron and Rasool (23) compared open fractures which have higher risk of infection due to 
contamination as compared to closed fractures. This is a very serious and concerning variable that cannot 
be ignored. There is no current study comparing non-union and implant sepsis in a single type of bone in 
closed fractures of HIV positive patients.  
The reaming technique has gained popularity in literature and has proven to increase the rate of fracture 
union in femur fractures (24). This technique is the local standard in all femur fractures treated with 
intramedullary nails. It is challenging to classify and adequately explain and interpret the complexity of 
fractures in long bones. This type of communication between professionals had to be standardised 
through classification systems. In literature it has also been proven that the AO classification is prognostic 
of outcome of closed femur fractures (25). The closed reamed femoral nailing technique gives a more 
predictive prognostic outcome of fracture healing in closed femoral fracture and minimises the variables 
of risk factors to non-union. This classification, though acceptable, like other classifications, still falls short 
of completely guiding the surgeon in all aspects of surgical intervention. 
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Timing of operative fixation 
In high-income countries, the standard of care is to offer surgical intervention to trauma patients as soon 
as possible after stabilisation at a health facility, or on the next available slate. This reduces the 
complications of trauma, enables rapid rehabilitation and return to work or functionality. This makes 
sense if the transport of the patient to the appropriate facility of care is suitably quick, the facility is well 
staffed and has primary equipment, theatre time and more importantly, skilled labour to perform the 
work at hand. This is a challenge in KZN (5). These challenges may result with presentation of trauma as 
long as five days after the actual incident and sometimes, longer. This results in fractures that are difficult 
to reduce because of the development of callus in a non-anatomical mal-aligned position. As a result, 
closed fractures may need to be converted to open reduction techniques in order to mobilise the sticky 
callus bone formation, thus reduce the fracture and allow locked femoral nailing. There is also a risk of 
the operation lasting longer and resulting in increased risk of sepsis and septic non-union (26). 
 The level of surgeon experience is also very important to consider. The more experienced surgeon is more 
likely to take much less time operating than a junior doctor. But, on the other hand, a more experienced 
surgeon is more likely to operate on more complex and challenging fractures than a junior surgeon. This 
factor may result in senior surgeons taking more time to perform a femoral nailing. The complexity of the 
fracture should be taken into account and graded to be able to measure this variable. The AO classification 
system has proven to be prognostic of femoral non-union while taking into account the complexity of the 
femoral fracture (25). This classification provides an idea of the amount of energy transferred to the 
fractured femur, the amount of periosteal contusion or disruption and the stability of the fracture site. 
These factors are very important to the clinical outcome of the operation and the patient’s morbidity i.e. 
malunion, shortening, progression angle and return to pre-morbid activity. 
Other variables 
There are other noted variables that contributes to implant sepsis and non-union. Smoking is a well-
documented factor causing non-union in fractured bones (9,11). Cigarettes have a lot of carcinogenic 
chemicals including nicotine.  Nicotine has an effect in inhibiting the process of neovascularization which 
is pivotal in fracture union early in the process of fracture healing. This aspect is part of lifestyle behaviour 
that can, though difficult, be modified or stopped entirely to improve the patient’s health in general. 
In 2011 Aird and co-workers (16,19,20) published their results of the effects of HIV on early wound healing 
in open fractures treated with internal and external fixation. The study was conducted between May 2008 
- 6 - 
 
and March 2009 at Ngwelezana hospital. The results of this study suggested that HIV is not a 
contraindication to internal or external fixation of open fractures, and HIV is not a significant risk factor 
for acute wound or implant infection. This study by Aird and co-workers’ work will act as a pilot to help 
understand the complexity of this complication of non-union and implant sepsis in HIV positive patients 
when compared to the HIV negative patients treated with locked femoral nailing in closed femur fractures. 
 
Conclusion 
Fractures are complex and the influence of HIV positivity on the outcome in terms of non-union and septic 
complications is not yet well-defined. This aspect requires further research. 
REFERENCES 
1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality 
from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden 
of Disease Study 2010. Lancet. 2012;380(9859):2095-128. 
2. Kruger N, O'Connor M, Ferreira N, Marais L. HIV seroprevalence and its relation to bone infection, 
bone tumours and limb reconstruction patients in a South African tertiary hospital. SA Orthop J. 2017; 
16:20-3. 
3. Kharsany ABM, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, 
Challenges and Opportunities. Open AIDS J. 2016; 10: 34-48. 
4. SA Statistical services. Population estimates. Census 2011. Census 2011 Statistical release – 
P0301.4 / Statistics South Africa. Pretoria: Statistics South Africa, 2012. www.statssa.gov.za accessed 
10/02/2019  
5. Hardcastle T, Oosthuizen G, Clarke D, Lutge E. Chapter 15: Trauma, a preventable burden of 
disease in South Africa: review of the evidence, with a focus on KwaZulu-Natal. In. Padarath A, King J, 
Mackie E, Casciola J, editors. South African Health Review 2016. Durban: Health Systems Trust; 2016: 179-
189. URL: http://www.hst.org.za/publications/south-african-health-review-2016  
6. Gaston MS, Simpson AHRW. Inhibition of fracture healing. J Bone Joint Surg Br. 2007;89-B 
(12):1553-60. 
- 7 - 
 
7. Gruen D. Wound Healing and Nutrition: Going Beyond Dressings with a Balanced Care Plan. J Am 
Col Certif Wound Spec. 2010;2(3):46-9. 
8. Bates J, Mkandawire N, Harrison WJ. The incidence and consequences of early wound infection 
after internal fixation for trauma in HIV-positive patients. J Bone Joint Surg Br. 2012;94-B(9):1265-70. 
9. Guo S, DiPietro LA. Factors Affecting Wound Healing. J Dent Res. 2010;89(3):219-29. 
10 Hernigou J, Schuind F. Smoking as a predictor of negative outcome in diaphyseal fracture healing. Int 
Orthop. 2013;37(5):883-7. 
11. . Nejad SB, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a 
systematic review. Bull World Health Organ. 2011;89:757-765. doi: 10.2471/BLT.11.088179 
12. Kinter AL, Hennessey M, Bell A, Kern S, Lin Y, Daucher M, et al. CD25(+)CD4(+) regulatory T cells 
from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-
specific T cell immune responses in vitro and are associated with favorable clinical markers of disease 
status. J Exp Med. 2004;200(3):331-43. 
13. Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and 
national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005-70. 
14. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national 
life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a 
systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. 
15. STATISTICAL RELEASE, P0302; Mid-year population estimates - 2017. REPORT. STATS SA: 2017. 
www.statssa.gov.za accessed 10/02/2019 
16. Howard NE, Phaff M, Aird J, Wicks L, Rollinson P. Does human immunodeficiency virus status 
affect early wound healing in open surgically stabilised tibial fractures? Bone Joint J. 2013;95-B (12):1703-
7. 
17. Harrison WJ, Lewis CP, Lavy CBD. Wound healing after implant surgery in HIV-positive patients. J 
Bone Joint Br. 2002;84-B(6):802-6. 
- 8 - 
 
18. Paiement GD, Hymes RA, LaDouceur MS, Gosselin RA, Green HD. Postoperative infections in 
asymptomatic HIV-seropositive orthopedic trauma patients. J Trauma. 1994;37(4):545-50; discussion 50-
1. 
19. Aird J, Noor S, Lavy C, Rollinson P. The effect of HIV on early wound healing in open fractures 
treated with internal and external fixation. J Bone Joint Br. 2011;93-B (5):678-83. 
20. Phaff M, Aird J, Rollinson PD. Delayed implants sepsis in HIV-positive patients following open 
fractures treated with orthopaedic implants. Injury. 2015;46(4):590-4. 
21. Nieuwoudt L, Ferreira N, Marais L. Short-term results of grade III open tibia fractures treated with 
circular fixators. SA Orthop J. 2016; 15:20-6. 
22. Winquist RA. Locked Femoral Nailing. JAAOS - Journal of the American Academy of Orthopaedic 
Surgeons. 1993;1(2):95-105. 
23. Seron S, Rasool MN. Outcomes of intramedullary nailing for open fractures of the tibial shaft. SA 
Orthop J 2018;17(1):24-29. 
24. Canadian Orthopaedic Trauma S. Nonunion following intramedullary nailing of the femur with and 
without reaming. Results of a multicenter randomized clinical trial. J Bone Joint Surg Am. 
2003;85(11):2093-6. 
25. Noumi T, Yokoyama K, Ohtsuka H, Nakamura K, Itoman M. Intramedullary nailing for open 
fractures of the femoral shaft: evaluation of contributing factors on deep infection and nonunion using 
multivariate analysis. Injury. 2005;36(9):1085-93. 
26. Malik MHA, Harwood P, Diggle P, Khan SA. Factors affecting rates of infection and nonunion in 
intramedullary nailing. J Bone Joint Br. 2004;86-B (4):556-60. 
 
 
Part 2: A submission ready manuscript. 
Abstract 271 words 
Introduction 
- 9 - 
 
It is unknown if there is a difference in short-term, or late implant sepsis and non-union rates between 
HIV positive and HIV negative patients treated with reamed, closed femoral nailing for closed femur 
fractures. 
Patients and Methods 
Between February 2011 and December 2012 all patients from a single referral hospital with a high rate of 
trauma and HIV prevalence with closed femur fractures included:  32 HIV positive patients and 80 HIV 
negative patients. Injury severity, age, AO/ASIF fracture pattern and CD4 counts were assessed. Wound 
sepsis was assessed with the ASEPSIS method. Radiological assessment for union was done. Telephonic 
follow-up was undertaken for late implant sepsis and non-union.  
Results 
No cases of early implant sepsis in either the 32 HIV positive or 80 HIV negative patients were noted at 
follow-up. One patient in the HIV positive cohort had a high ASEPSIS score, deemed a superficial infection 
which resolved on antibiotics.  A 3-year telephonic assessment of 32 HIV positive patients and 71 HIV 
negative patients with implants in situ and was undertaken. No sepsis was detected in the HIV(-) group 
and one case of sepsis in the HIV(+) group that resolved after nail removal in a patient who was initially 
HIV negative and later sero-converted.  No cases of non-union in either group was noted at 3 year follow-
up. 
Conclusions 
We found no increased risk of sepsis in closed internally fixated femoral shaft fractures HIV(+) patients 
and concludes that there is no apparent increased risk of late, implant sepsis. There does not appear to 
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Comparative Study of Intramedullary Nailing of Closed Femur Fractures in HIV Positive and HIV Negative 
patients  
Introduction  
Human immunodeficiency affects 38.8 million people globally, with 1.2 million new HIV infections in 2015 
and with 75.4% of all infections in sub-Saharan Africa in 2015 (1). There are 5 million people affected in 
South Africa with 18% in the adult population between aged between 15years and 49years of age 
infected.(1) A particularly high prevalence exists in the province of KwaZulu-Natal (KZN) which is the 
second most highly populated province in South Africa.(1)  This area also has a high trauma rate due to a 
multiplicity of causes such as interpersonal violence, gunshot wounds and high energy injuries caused by 
motor vehicle collision (MVC) with a large proportion of these being pedestrian vehicle collision (PVC). 
Recent statistics rank South Africa 42nd highest in the world in the road mortality rate (WHO - 2013) (2, 
3) with 31.9 deaths per 100 000 population of which 37% were PVAs.      
 
There were initially major concerns about treating HIV positive patients with internal fixation because of 
fears regarding both early and late implant sepsis. Research from the 1990s and early 2000s (4-6) 
suggested very high rates of implant sepsis especially in open fractures and there was a tendency to 
manage some fractures that would normally have been internally fixed in HIV negative patients, by other 
means and avoid internal fixation. More recent literature has suggested that early implant infection rates 
in HIV positive patients are not significantly different from infection rates in HIV negative patients in closed 
fractures, arthroplasty and also in open fractures.(5, 7, 8) Also the concern over late implant sepsis in HIV 
positive patients is not supported in the paucity of the literature that has addressed this issue.(8, 9) 
 
There has also been concern regarding delayed and non-union of fractures in HIV positive patients. 
Harrison (10) reported delay in times to union in open tibial fractures treated initially by external fixation 
and then converted to plaster, though other studies have not shown statistical differences in union times 
in HIV positive cases compared to HIV negative cases (11). 
 
We performed a retrospective, observational, comparative study of prospective cohorts of HIV negative 
and HIV positive patients, treated by interlocking nailing of closed femur shaft fractures in a single 
institution with a high trauma load and high HIV positive prevalence. We compared early infection rates 
and non-union rates and also did a long term follow up looking specifically at late infection rates and non-
union rates in both cohorts of patients.    Almost three million people live in the area of northern KwaZulu-
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Natal in South Africa and are referred to a single trauma centre from 14 district hospitals (12). There is a 
local, catchment population of 334,459 people in the area served directly by the trauma centre (12). 
 
Patients and Methods  
Over a 23-month period from February 2011 to December 2012, all adult patients with femur fractures 
admitted to the trauma unit were recruited for the study.  Inclusion criteria were patients 16 years or 
older with closed femur shaft fractures that were treated by a standard, reamed 10 mm interlocking nail 
with post-operative clinical and radiological follow up for 6 months or more and long-term telephone 
follow up of 3 years or more. Proximal femur fractures that required fixation with a more complex type 
of nail, with proximal fixation along the neck of femur, were not included in the study. Further exclusion 
criteria were femur fractures initially treated with external fixation and later converted to an interlocking 
nail, femur fractures that were plated, open fractures including GSW fractures and patients who could not 
be followed up adequately. Patients with an unknown HIV status and refusal to be tested were also 
excluded. Additionally, polytrauma cases with other injuries that might cause an increased risk of sepsis 
in the nailed femur, such as open fractures in the same limb or a laparotomy for bowel injury, were 
excluded.      
 
Patients were routinely encouraged to be HIV tested and counselled as part of the protocol for inpatients 
in the hospital. Testing and counselling were done by Health Care workers (HCWs) not involved in the 
study. Patients already on ARV treatment had their treatment continued whilst in hospital and in keeping 
with the national protocol regarding the CD4 count in 2011 and 2012, (13) patients with CD4 counts below 
350 cell/ul or patients with signs of clinical AIDS, were started on treatment, usually after their discharge 
from hospital. The national protocol of commencing ARV therapy to all HIV positive patients, irrespective 
of CD4 count, only commenced in 2016 (6). Twelve HIV positive patients were on ARV therapy at the time 
of their admission with CD4 counts ranging from 22 – 1551.53 cells/ul with a mean of 602.73 
 
Ethical approval for the initial part of the study was obtained from the hospital ethics committee and later, 
approval for the longer follow up was obtained from the UKZN Biomedical Research Ethics Committee 
(BREC), BREC ref: BE354/14. 
 
All patients were treated by closed, ante-grade intramedullary locking nails after reaming with Smith and 
Nephew 10mm diameter Trigen nails (Smith and Nephew, Memphis, Tennessee). Operations were 
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scheduled for routine trauma lists and were done within a few days of admission to the trauma centre. 
Delays in operations from the time of injury were generally because of delays in transferring patients from 
district hospitals to the trauma centre. Operations were performed by specialists and medical officers, 
either experienced or under supervision.        
 
A number of clinical parameters were recorded including alcohol intake, smoking, AO/ASIF classification 
of the fracture, operating time (measured from incision to closure of the wound), level of expertise of 
operating surgeon, New Injury Severity Score (NISS), number of operations performed on the patient for 
additional injuries and categorization of the fracture as high or low energy. The AO/ASIF fracture 
classification was done by one investigator (MK) reviewing all X-rays on Picture Archiving and 
Communicating System (PACS; Agfa HealthCare, Mortsel, Belgium). 
 
Initial follow up was done by one investigator (M.P.) in the routine fracture clinics with clinical assessment 
and X-rays taken at 4 weeks after discharge with further follow up and X-rays taken between 2 – 12 
months post operatively until clinical and radiological union was established. Clinical union was regarded 
as the ability to walk unaided with no discomfort and radiological union was regarded as bridging callus 
seen on 3 or more cortices on A-P and lateral X-rays.(8, 14) Surgical wounds were assessed for signs of 
infection using the ASEPSIS score.(15) The ASEPSIS score  has been used by this unit and others in previous 
publications.(8, 9) For the long term follow up, a telephone-based follow up questionnaire (Fig. 1 – 
telephonic ques) was then performed by one investigator (MK) at least 3 years after the initial operation. 
A similar questionnaire has been used previously in this unit in a study by Phaff and co-workers (8) and 
was a combination of some aspects of the ASEPSIS score as used by Bates (5, 9) and non-union criteria as 
used by Hernigou and Frederic (14) and was directed at assessing late implant sepsis and non-union.  
Figure 1. Telephonic questionnaire. 
 
  
Pain from injury at present No pain Little pain A lot of pain 
Pain wakes me up at night Yes/no 
Walking aid 
(For lower limb injuries) 
None 1 x crutch 2 x crutches 
Walking frame Wheelchair Bedridden 
Can use arm to dress 
(for upper limb) 
Yes/no 
Are the joints involved stiff? Yes/no 
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Wounds on the affected limb No wounds Small wound <2cm 
Big wounds >2cm Many wounds >1 
Discharge from wounds Yes/no 
RVD status Positive  Negative Unknown  
Last CD4 count  
Date Last CD4 count  
On ARVs Yes/no 
When started on ARVs  
Metal removed Yes/no 
 
Statistical analysis  
The data collected was represented as categorical data and collected into a database compiled in 
Microsoft Excel (Microsoft, Redmund, WA) where further graphical representation of the data was also 
generated. The statistical analysis was performed with PAST version 3.24 (O Hammer, Oslo, Norway) and 
within each sub-category significance testing was performed with Chi-squared test with a significance 
level set at p < 0,05.  A multivariate analysis was done to establish the association of each of the variable 
with our outcome (non-union and implant sepsis) using Chi-Squared p-value and Mann-Whitney U. A 
significant difference was considered if any of the variables has a p-value of p < 0.05.  
 
Results  
A total of 147 patients with femur fractures were initially recruited into the study but 35 patients were 
excluded because of refusal to be HIV tested or inadequate follow up. This gave a total of 112 patients 
included in the initial part of the study. For the long term follow up, 7 patients were lost to follow-up and 
this gave a total of 105 patients in the longer follow up at 3 years or more. There were two patients in the 
study group who had bilateral femur fractures. One patient had a femur nailed with the opposite side 
plated. The second patient has both femurs nailed. Subsequently, at 3 months in the patient with bilateral 
nails, one nail broke at the distal screw hole and was revised to a locking plate and this nail breakage was 
regarded as a mechanical failure.  These 2 patients were included in the study giving a total of 112 patients 
(with 113 femoral nails) in the initial part of the study and a total of 105 patients with 105 nailed femurs 
in the longer-term study. Fig.2 (flowchart) 








There was only one case of early wound sepsis in the HIV positive group and no cases of sepsis in the HIV 
negative group noted in the initial clinical assessment performed in the first 12 months post-operatively. 
The one HIV positive patient with sepsis had an ASEPSIS score of 26 at his 4 weeks follow up and a wound 
swab cultured Enterobacter. He was started on antibiotics with complete resolution of the sepsis when 
reviewed four weeks later and there was no suggestion of sepsis at the 3 year follow up. This high ASEPSIS 
score was therefore assumed to be a superficial soft tissue infection and not an implant sepsis. There was 
therefore no implant sepsis in either the HIV positive or HIV negative groups during the first part of the 
study, concluding at 1 year.  
 
Fig. 2. Flowchart giving an overview of both the 1 year and more than 3 years follow-up 
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All fractures in the HIV positive group had united by 6 months and all but two (2,5%) in the HIV negative 
group had united at 12 months. Of these 2 failures in the HIV negative group, one was in a patient with a 
broken nail that was revised to a locking plate at 3 months, which subsequently united and the second 
failure was a non-union that was revised to a plate at 9 months post-operatively and united after plating.  
Risk factors such as smoking (14), alcohol intake and poverty (risk factors for poor lifestyle and nutrition 
(16, 17), were recorded, but were not related to non-union or implant failure.    
 
Overall, 77 of the totals of 112 patients (68.8%) were classified as high energy injuries mainly caused by 
motor vehicle collisions (MVC) 58 patients (p-value: 0,283) and pedestrian vehicle collisions (PVC) 19 
patients (p-value: 0,036). Forty-nine of the 80 HIV negative patients (61.25%) sustained high energy 
fractures compared to 28 of 32 HIV positive patients (87.5%). The AO/ASIF classification of the femur 
fractures for the HIV positive and HIV negative groups is shown in (Fig. 3 – AO) B2 and B3 fractures 
predominated in the HIV positive group with there being eight (25%) B2 fractures (bending wedge) and 
eight (25%) B3 fractures (comminuted wedge) in this group of 32 patients. (Fig. 4- NISS) In the HIV negative 
group, A type fractures predominated, with 44 of the 80 fractures (55%) being A1 (7.5%), A2 (16.25% & p-
value: 0,07) or A3 (31.25% & p-value: 0,008). The majority of patients, 85 of 112 (75.9%) had a NISS of 9 
(p-value: 0,0002), indicating only an isolated femur fracture. The median NISS was 9 in both HIV negative 
and HIV positive patients. The HIV positive group had a mean age of 35 years compared to a mean age of 
31.6 in the HIV negative group. Eighteen of the 32 HIV positive patients were aged 30 – 39 years (56%) 
compared to only 12 of the 80 HIV negative group in their 30s (15%). There were 16 males and 16 females 
(50%) in the HIV positive group and 59 males and 21 females (26.25%) the HIV negative group. 
 
 










There were 32 HIV positive patients in the study with CD4 counts available in 25, ranging from 22 – 
1551.53 cells/ul with a mean of 602.73. Seven patients had CD4 counts <350 cell/ul. Eighty patients were 
HIV negative when they entered the study and of these, 3 patients later sero-converted and became HIV 
positive at the 3-year telephone follow up.  
 
Operative time was less than 60 minutes for 42 of total of 112 patients (37.5% & p-value: 0,042), between 
60 – 120 minutes in 66 of the cases (58.93% & p-value: 0,026) and more than 120 minutes in 10 patients 
(8.9% & p-value: 0,297). These prolonged operative times were recorded in patients requiring additional 
procedures after their femurs were nailed e.g. tibial nail, forearm fixation for multiple fractures. Eighty of 
the 112 patients were operated on by medical officers (71.4% & p-value: 0,0032) with consultants 
operating on 32 of the total (28.6% & p-value: 0,019) (Fig. 5).  
Fig. 3. AO classification of femur fractures showing high percentage of Type-A fractures (44 of 80 
fractures) in the HIV negative patients (55%) and high percentage of Type-B fractures in HIV 
positive patients (56%) with 8 (25%) B2 fractures (bending wedge) and 8 (25%) B3 fractures 
(comminuted wedge) 
Fig. 4. NISS showing majority, 85 of 112 (75.9%) of patients (75.9%) with a low score of 9 
indicating an isolated femur fracture. 





At the 3-year follow-up, a total of 105 patients out of the original 112 were contacted and assessed with 
the telephonic questionnaire, specifically assessing late sepsis and non-union. Of the original cohort of 32 
HIV positive patients, telephone contact was made with 29 and no patients were found at 3 year follow 
up to have any suggestion of late sepsis or non-union. Of the 80 patients in the original HIV negative group 
telephonic assessment was possible with 76 patients and there was one patient with suspected implant 
sepsis. This was a patient who was initially HIV negative at the time of femoral nail insertion and so was 
initially included in the HIV negative cohort. He later sero-converted and developed a sinus at the site of 
nail insertion and had the nail removed at 24 months post-operatively because of suspected implant 
sepsis, which resolved after nail removal, without antimicrobials. This patient was therefore included in 
the HIV positive cohort in the longer follow up. Two patients from the HIV negative group had their nails 
removed for mechanical irritation after 1 year and prior to their 3 year follow up. Their fractures had 
already united with no signs of sepsis when the nails were removed and although there was no sepsis 
noted at the 3 year follow up, they were not included in the numbers for the long term follow up of late 
Fig. 5. Operative time was less than 60 minutes for 42 of total of 112 patients (37.5%), 
between 60 – 120 minutes in 66 of the cases (58.93%) and more than 120 minutes in 10 
patients (8.9%). These prolonged operative times were recorded in patients requiring addition 
procedures after their femurs were nailed e.g. tibial nail, forearm fixation for multiple 
fractures. Eighty of the 112 patients were operated on by medical officers (71.4%) with 
consultants operating on 32 of the totals (28.6%) 
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implant sepsis. Two further patients from the HIV negative cohort had sero-converted and were therefore 
included in the HIV positive group for late follow up but they were in the HIV negative cohort for 
assessment of early sepsis.  
 
Discussion   
The results of the current study support the hypotheses that that there is no association between HIV 
positivity and early and late implant sepsis and also no association between HIV positivity and non-union 
in closed femoral fractures treated by closed, reamed nailing. This study compared a relatively large 
cohort of HIV positive patients (32) with a larger cohort of HIV negative patients (80) treated at a single 
institution with a standardized operation and found low rates of infection in both cohorts with both short-
term follow up and then longer term follow up at >3 years. These results are in keeping with other studies 
looking at wound infection and implant sepsis in HIV positive patients with closed fractures. An early 
prospective study from Malawi (18) comparing wound infection rates in 28 HIV positive patients and 108 
HIV negative patients treated by internal fixation showed no statistical difference between the two 
groups.  More recent studies by Bates in 2012 (5) also from Malawi, compared a large series of 118 HIV 
positive patients with 418 HIV negative patients and smaller series by Hao et al  in 2015 (19) from Denver, 
USA confirm the findings of no increased risk of early implant sepsis in HIV positive patients.  
 
Early studies by Piaiemont in 1994 (20) and Harrison in 2002 (18) raised concerns about sepsis risk with 
open fracture treatment and subsequent studies have produced differing results. Howard and co-workers 
(21) reported lower infection rates in a cohort of HIV positive patients with open tibial fractures treated 
by both internal and external fixation and Aird,(7) from the same research group, showed no statistical 
difference in early infection rates between HIV positive and HIV negative patients treated with internal 
and external fixation although Grade 1 open fractures with low CD4 counts did show a statistically 
significant increase in wound infection rates. A further paper from South Africa, by Nieuwouldt and co-
workers (22) looking specifically at open grade III tibial fractures treated by a circular external fixator, 
showed very low sepsis rates in both HIV positive and negative patients (4.3%) and no difference in 
infection rates between the two groups.    
 
There is a paucity of evidence regarding late implant sepsis in HIV positive patients. There is a concern 
that as HIV disease progresses and immunity falls, implant sepsis may increase as seems to happen with 
reactivation of old haematogenous osteomyelitis (23). Prospective studies from Malawi by Harrison (10) 
- 20 - 
 
and Graham (9) showed no late implant sepsis in patients with closed fractures with follow up for 12 
months and 27 months respectively. Low rates of late implant sepsis in open fractures were also recorded 
by Graham (9) with no sepsis noted in 12 patients.  Phaff and co-workers (8) recorded sepsis rates of 8% 
in both HIV positive and HIV negative patients with a follow up period of over 3 years in patients with 
open fractures and implants still in place.  A different way of looking at chronic bone infection rates in HIV 
positive patients was explored by Kruger and co-workers (24) who retrospectively reviewed 303 patients 
referred to a tertiary unit with chronic bone infection, mostly without implants. They noted a similar rate 
of HIV positivity in their patients with chronic osteomyelitis (24.5%) as existed in the local adult population 
(21%), implying that HIV may not be a significant risk factor in chronic osteomyelitis.    
 
Union of fractures is usually defined by a combination of clinical and radiographic criteria, the most 
commonly used being the absence of pain or tenderness at the fracture site and the presence of bridging 
callus at the fracture site (25). Radiological union is usually defined by bridging callus seen on three 
cortices on standard A-P and lateral views (14). Non-union rates in nailed femur fractures vary from 0% 
(26, 27) up to 5% and 7% respectively in series reported by Hammermacher (28)  and Herscovici (29). 
These latter two papers however reported on unreamed nails and other studies comparing reamed and 
unreamed nails in femur fractures have confirmed higher non-union rates in unreamed as compared to 
reamed nailing techniques. A multicentre, randomized trial from the Canadian Orthopaedic Trauma Team 
(30) compared a series of 107 unreamed femur fractures treated with a smaller diameter nail with 121 
fractures treated with a relatively larger diameter nail after reaming and noted a 7.5% non-union rate in 
the unreamed group compared to a 1.7% non-union rate in the reamed group.  
 
Delayed and non-union of fractures in HIV positive patients with both open and closed fractures has been 
assessed in few papers, many of which do not give their methods of assessment or detail for determining 
delayed and non-union. Harrison 2004 (31) recorded 0% non-union in 26 HIV positive patients with closed 
fractures assessed both clinically and radiologically. Hau and co-workers (19) recorded no non-unions in 
their series of 24 closed fractures in HIV positive patients.  Phaff (8) in his long term follow up of implants 
in HIV positive patients with open fractures, recorded 1 patient out of 13 HIV positive patients (7.5%) with 
non-union after external fixation of a tibial fracture. This was in a patient with a low CD4 count (105 
cells/uL) who eventually united after conversion to a nail. Nieuwouldt and co-workers (22) in a 
retrospective review of 94 consecutive grade III open fractures treated definitively by circular frame 
fixation, recorded no non-unions in 31 HIV positive patients. Studies by Abalo and co-workers (32) and 
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Aird and co-workers (7), however recorded higher rates of non-union in open fractures at 11 % and 15% 
respectively, but many of the risk factors for non-union were not recorded in these papers.  In our series, 
all the femur fractures were reamed and nailed with a relatively large nail (10 mm diameter) and our low 
non-union rates in both the HIV positive and negative groups (0% and 1.25% respectively) are comparable 
to those recorded in earlier studies. Tornetta (27) recorded no non unions in 89 reamed femurs and the 
Canadian Orthopaedic Trauma Society (30) recorded 2 non unions in their series of 121 reamed femurs.         
 
In our series the HIV positive group had a higher percentage of high-energy injuries (87.5%) compared to 
the HIV negative group (61.25%) with only 4 out of 32 fractures being classified as low energy injury in the 
HIV positive group. Also, the HIV positive group had a high percentage of type B fractures (56.25%) 
compared to HIV negative group (33.75%), reflecting a more severe type of fracture pattern. These 
findings are surprising considering that HIV disease and ARV treatment are both thought to cause a 
decrease in bone density and osteoporosis (33) and the expectation would be that low-energy fractures 
would be more frequent in HIV positive patients compared to HIV negative patients. One consideration is 
that HIV positive patients may take more risks in their daily life especially when travelling, for instance, 
not using seat belts and travelling in the back of open vehicles. 
 
The low median NISS score of 9 in this study is surprising considering the high rate of high energy injuries 
in both the HIV positive (87.5%) and HIV negative groups (61.25%) and with a total of 77 patients out of 
the 112 patients being involved in vehicle related trauma either as a car occupant or as pedestrian. This 
anomaly is explained by the large numbers of patients with femur fractures excluded from the study 
because of their associated injuries such as a laparotomy for a bowel injury or an associated open fracture 
in the same limb as the nailed femur fracture. These cases were excluded because these associated 
injuries could have resulted in an increased sepsis risk in the nailed femur fracture. In fact, the majority of 
patients in the study, 85 (75.9%), had a NISS score of 9, reflecting only a femur fracture as an isolated 
injury.       
 
Human immunodeficiency virus (HIV) disease is associated with loss of CD4+ T cells, chronic immune 
activation and progressive immune dysfunction (33). There were seven HIV positive patients with CD4 
counts <350cell/uL out of the total of 32 HIV positive patients followed up in the first part of the study. 
This figure of CD4 count of <350 cells/uL is noted because it has been regarded as signifying advanced HIV 
disease (7) and was also the level when ARV treatment was initiated according to the guidelines of South 
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African Dept of Health in 2010 (13) and these were the guidelines in place at the time of this study (7).  
None of these patients with low CD4 counts showed any evidence of the development of sepsis or non-
union in the short term or longer follow up study. Most studies of HIV implant sepsis have very few 
recorded low CD4 counts and it is difficult to draw any conclusions regarding low CD4 counts and a 
possible increased risk of implant sepsis (7)    
    
Long-term anti-retroviral (ARV) therapy, with certain treatment regimes, is now known to be a factor in 
the osteoporosis and fragility fractures seen in HIV patients on ARVs, but it is difficult to differentiate the 
effects of the drug treatment from the effects of HIV disease itself (33). ARV therapy, particularly therapy 
with tenofovir and ritonavir-boosted protease inhibitors (rPIs), reduces bone mineral density (BMD) (33) 
and predisposes to fragility fractures, increased bone turnover and possibly increases the risk of poor 
bone healing.  In South Africa, with 7.1 million people living with AIDS in 2016 (1, 34) and nearly 4 million 
on ARV’s, fractures rates associated with ARV therapy, can only be expected to increase.  
 
There are a number of limitations to this study. The low risk of both infection and non-union in closed 
femur fractures treated by reamed intra-medullary nails means that the numbers in the study are not 
sufficiently powered to show statistical differences for both infection and non-union. The long-term follow 
up by telephone interview is not as rigorous an assessment as a clinical and radiological follow up. The 
intention with the telephone follow-up, was to call back patients with problems suggestive of sepsis or 
non-union and assess these patients both clinically and radiologically, but since there were no patients 
with problems, this more detailed follow up was not required in any patient.  Although the initial clinical 
and radiological follow up was prospective, the assessment for infection using the ASEPSIS score was not 
blinded and so an element of bias and subjectivity could be present.   Some of the strengths of this study 
are that the cohorts of patients are homogenous, all with closed femurs with no other risk factors for 
sepsis, with very standardized operations done in one centre. This study adds to our knowledge 
documenting long term follow up of HIV patients with implants. 
 
In conclusion, this study again found no increased risk of sepsis in closed femur fractures treated by 
internal fixation in HIV positive patients, yet also adds to the paucity of literature regarding long-term 
implant sepsis in HIV positive patients and concludes that there is no apparent increased risk of implant 
sepsis. Also, there does not appear to be an increased non-union rate in HIV positive patients treated by 
reamed nailing of closed femur fractures.  
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Take home message 
• There’s very high prevalence of HIV/AIDS in the Sub-Saharan Africa with also very high trauma 
rates. 
• This study confirms both in short-term and long-term follow-up, there is no statistical difference 
in infection rates between HIV positive and HIV negative patients treated with femoral nails in closed 
femur fractures.   
• Seven of the 32 patients had low CD4+ counts (<350 cells/ul) and no clinical manifestation of AIDS. 
None of these patients had any sepsis or non-union. There is still however concern regarding implants 
sepsis in patients with clinical manifestation of AIDS and very low CD4+ count (<100 cell/ul) 
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Appendix 1: The final Study Protocol (Include the final protocol which was given full approval by Brec 
and/or the postgrad office) 
APPLICATION FOR EXPEDITED REVIEW 
1. ADMINISTRATIVE DETAILS 
NAME: PI - Prof/Dr/Mr/Mrs/Miss/Ms 
NAME: Co-investigator 
Dr Mmakgabo Matthews Keetse 
Dr Martin Phaff 
Professional Status (if student, year of 
study) 
Medical Doctor, Orthopaedic Registrar 2nd year 
Full time/Part time Full Time 
UKZN Department  & Campus 
(Full Address) 
UKZN Medical School 
Hospital / Institution 
(where employed, Full Address)  
King Edward VIII Hospital 
Contact Telephone Numbers and 
email address  
084 700 9745 
HPCSA Number (or equivalent statutory 
health council registration no. as 
appropriate) 
MP0662836 
Title of Study: 
Delayed implant sepsis and non-union in HIV positive with 
intramedullary nails for closed femur fractures 
2.   Will there be direct participant contact?  YES* / NO 
 If YES, please explain and attach Informed Consent and Information Sheets  
Telephonic follow up of participant to complete the study project 
 
3. Where will the Research be carried out? (Hospital, clinic etc). 
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Hospital - Ngwelezana 
4. Is this a retrospective study?  YES, It’s a retrospective review of a prospective cohort 
      (a)  Tick type of study: Other:  Retrospective analysis of a prospective cohort study  
5.   Will participants’ confidentiality be maintained? YES  
Explain: The participants are offered a specific number to their name that will be used 
in the review of their results to keep their name confidential 
6.   Will Informed Consent be obtained?   YES / NO 
 Explain: 
The study and its aim have been explained in the language of the patient and 
participation purely voluntary. The minimum admission age of our participants is 16yrs 
and patient below 18yrs we still need the parent to countersign for admission into the 
study 
7.  Is this project intended to produce any information of diagnostic significance to the 
patient?  YES  
If yes, will such information be forwarded to the patient’s physician?  
- In the event were the patient’s implant turns septic the patient will be re-admitted 
and further definitive care will be instituted. 
8.   Proof of concept – justify scientific validity of project. 
There is much reluctance in the use of implants in the HIV positive population and this create 
much difficulty and uneasiness when having to treat this population where the use of implants 
is definitively indicated and the use the of will maximize their treatment 
9. Motivation for (justify) expedited review: 
Of the available studies, the have been a great challenge in the long term follow up of 
patient with implants especially in the trauma population. This creates a good 
understanding in the mid to long term follow-up of this patient and help evaluate if 
there is any differences between the HIV negative and positive population that supports 
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the fears already in existence in the surgical and medical fields and will help in decision 
making to optimize the treatment in the HIV positive population 
 
10.   I certify that all information provided above is correct and that it will apply throughout 
the performance of the proposed research and that I shall be responsible for the 
safeguarding of the confidentiality of human subject’s information involved. 
 
I agree to comply with the UKZN Biomedical Research Ethics Committee’s Terms of 
reference and the SA Department of Health (2004) Ethics in health research: Principles. 
Structures and processes, and, if applicable, the SA Department of Health (2006) South 
African good clinical practice guidelines. All are available at 
http://research.ukzn.ac.za/ResearchEthics11415.aspx  
Signature of Researcher: ORIGINAL SIGNED COPY SUBMITTED TO BREC  
Names and signatures of supervisor(s), co-workers/co-investigators: 
1) Mr Timothy Craig Hardcastle (Primary Supervisor) 
2) Mr Paul Rollinson (co-supervisor) 
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Appendix 2: The Guidelines for Authorship for the Journal selected for submission of the manuscript 
Guide for authors: Injury 
Injury was founded in 1969 and is an International Journal dealing with all aspects of trauma care. Our 
primary aim is to facilitate the exchange of ideas, techniques and information between all members of 
the trauma team. 
Topics covered include: trauma systems and management; surgical procedures, epidemiological studies, 
surgery (of all tissues) resuscitation; biomechanics, rehabilitation, anaesthesia; radiology, basic science 
of local and systemic response to trauma and tissue healing. 
The Journal also publishes a series of scientific supplements, all of which undergo peer-review prior to 
publication. 
The language of the journal is English (UK), for example, stabilisation, haematology, anaesthetic, centre, 
paediatric, mobilise. 
Open Access  
This journal offers authors two choices to publish their research;  
1. Open Access  
• Articles are freely available to both subscribers and the wider public with permitted reuse 
• An Open Access publication fee is payable by authors or their research funder 
Subscription  
• Articles are made available to subscribers as well as developing countries and patient groups through 
our access programs (http://www.elsevier.com/access)  
• No Open Access publication fee 
All articles published Open Access will be immediately and permanently free for everyone to read and 
download. Permitted reuse is defined by your choice of one of the following Creative Commons user 
licenses: 
Creative Commons Attribution-Non-commercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, 
lets others distribute and copy the article, and to include in a collective work (such as an anthology), as 
long as they credit the author(s) and provided they do not alter or modify the article. 
Creative Commons Attribution (CC-BY): available only for authors funded by organizations with which 
Elsevier has established an agreement. For a full list please see http://www.elsevier.com/fundingbodies 
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Elsevier has established agreements with funding bodies. This ensures authors can comply with funding 
body Open Access requirements, including specific user licenses, such as CC-BY. Some authors may also 
be reimbursed for associated publication fees. http://www.elsevier.com/fundingbodies 
To provide Open Access, this journal has a publication fee which needs to be met by the authors or their 
research funders for each article published Open Access. Your publication choice will have no effect on 
the peer review process or acceptance of submitted articles. The Open Access publication fee for this 
journal is $2500 USD, excluding taxes. 
Learn more about Elsevier's pricing policy http://www.elsevier.com/openaccesspricing 
Authors can share their research in a variety of different ways and Elsevier has a number of green open 
access options available. We recommend authors see our green open access page for further 
information (http://elsevier.com/greenopenaccess). Authors can also self-archive their manuscripts 
immediately and enable public access from their institution's repository after an embargo period. This is 
the version that has been accepted for publication and which typically includes author-incorporated 
changes suggested during submission, peer review and in editor-author communications. Embargo 
period: For subscription articles, an appropriate amount of time is needed for journals to deliver value 
to subscribing customers before an article becomes freely available to the public. This is the embargo 
period and begins from the publication date of the issue your article appears in. This journal has an 
embargo period of 12 months. 
Preparation of Manuscripts 
Title page: The first page must include the title of the article, names, initials and appointment of each 
author, name of the department(s) and institution(s) to which the work should be attributed and name, 
address, phone/fax and e-mail details of the author for correspondence and to whom reprints should be 
sent. Please note that it is essential to include the email address of the corresponding author, as proofs 
will be sent by email as attached PDF files. 
Keywords: up to 10 keywords must be included. 
Abstract: This should start on the second page of the manuscript and be not more than 350 words in 
length. It should be easy to read and where appropriate should be structured. The structure may follow 
the same format as the structure of the paper itself. 
highlights: Please provide 3-5 highlights that clearly and succinctly convey the key messages of your 
paper. Each highlight should be no more than 125 characters (without spaces) on a separate page and 
double-spaced. 
Text: This should start on the third page, and will normally be divided into the following sections: 
Introduction, Materials (or Patients) and Methods, Results, Discussion and Conclusions, but other 
descriptive headings and subheadings may be used if they are felt to be more appropriate. 
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Introduction should explain the purpose of the study or investigation, the clinical relevance and the 
background provided by previous research, or publications, in this area and, where appropriate, a 
statement of approval by an Ethical Committee. 
Materials (or Patients) and Methods should give details of inclusion and exclusion criteria for patients in 
clinical trials, research methodology, systems of assessment, or measurement, with appropriate 
references and the statistical analyses used. Any proprietary equipment or apparatus used should be 
named, along with the manufacturer's name and address. Sufficient detail should be given to allow 
other investigators to repeat the study. Where relevant, tables or figures may be included to provide 
information more clearly. No data should normally be presented in this section. 
Unnecessary experimental detail should be avoided, but appropriate references should be cited. 
Results should give all the relevant data, presented in a concise and meaningful way, with tables or 
figures to present data more clearly or concisely, where appropriate. In studies with well under 100 
subjects, percentages are not accepted. 
Discussion should consider the results and possible confounding factors, sources of bias, weaknesses in 
the study and a review of the relevant literature, putting the results of the study in the context of 
previous work in this area. 
Conclusions must be based on the results presented. 
References:  
References should be listed in numerical sequence as they are cited in the text. Names of the first six 
authors are to be provided. The reference style is based on the 'Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals' (http://www.icmje.org). Both journal and book references should 
contain inclusive page numbers. 
Personal communications and unpublished data should be cited in parentheses in the text, and not 
included in the numbered reference listed at the end of the article. Such citations from someone other 
than the authors (e. g., personal communication) can only be published if a signed letter of permission if 
provided. 
References to abstracts should be included only when essential, and then only if the abstract is from a 
readily accessible periodical (e.g., Federation Proceedings: FEBS Abstracts). Such references must 
contain the word (Abstract) after the title. 
References in the text should be identified by superscript numbers, inside punctuation at the end of the 
sentence, and numbered in order of appearance. Along with the entire manuscript, references should 
be double spaced. 
Data references 
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This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in 
your text and including a data reference in your Reference List. Data references should include the 
following elements: author name(s), dataset title, data repository, version (where available), year, and 
global persistent identifier. Add [dataset] immediately before the reference so we can properly identify 
it as a data reference. This identifier will not appear in your published article. 
Examples of References  
Journal Articles 
1. Standard Journal Articles (List all authors when six or less; when seven or more, list the first six and 
add et al. Do not repeat page numbers). 
Frame JD, Frame JE. Modifying integra as a regeneration template in deep tissue planes. J Plast 
Reconstruct Aesthet Surg 2006;59: 460-4. 
Books  
1. Book chapter 
Lister GD. Skin flaps. In Green DP, editor. Operative Hand Surgery. 3rd ed. New York: Churchill 
Livingstone; 1993, p. 1741-1823. 
2. Book 
Book: Mathes SJ, Nahai F. Reconstructive Surgery: principles, anatomy, and technique. New York: 
Churchill Livingstone; 1997. 
Website  
Uebersax J. A practical guide to local dependence in latent class models. 
http://ourworld.compuserve.com/homepages/jsuebersax/condep.htm. 
Dataset 
[dataset] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and 
surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1. 
Authors are strongly encouraged to check the accuracy of each reference against its original source. 
Abbreviations: In general abbreviations should be spelt out in full the first time they are used, but this 
does not apply to the very common abbreviations listed below: A&E: accident and emergency; CT: 
computed tomography; DVT: deep vein thrombosis; EUA: examination under anaesthetic; GA: general 
anaesthetic; ICU: intensive care unit; IM: intramedullary; ISS: injury severity score; ITU: intensive therapy 
unit; IV: intravenous; LA: local anaesthetic; MRI: magnetic resonance imaging; MUA: manipulation under 
anaesthetic; OR: operating room; ORIF: open reduction and internal fixation; XR: X-ray (examination). 
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Units of measurement should all be in SI units, except for measurements of blood pressure, where mm 
Hg is preferred. For more detailed recommendations authors should consult Baron D.N. (ed.) (1977) 
Units Symbols and Abbreviations: A Guide for Biological and Medical Editors and Authors, 3rd Ed. 
London, Royal Society of Medicine. 
For drugs and chemicals, the generic name should be used, but trade names may follow in brackets. 
Tables: Each Table, with an appropriately brief title, should be numbered and printed on a separate 
page. No vertical lines should be used. All tables should be referred to by number in the text. 
Figures: Figures should be limited to those considered essential. Colour illustrations incur an additional 
cost to the author and should only be used if they illustrate important points not demonstrable in black 
and white. Line drawings should be professionally drawn, with lettering large enough to remain legible 
after reduction. A list of figure legends must be supplied on a separate sheet of the manuscript. 
Allillustrations should be referred to in the text. 
Accepted Manuscripts Copyright Information 
Upon acceptance of an article, authors will be asked to sign a 'Journal Publishing Agreement' (for more 
information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the 
agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent 
to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement.  
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal 
circulation within their institutions. Permission of the Publisher is required for resale or distribution 
outside the institution and for all other derivative works, including compilations and translations (please 
consult http://www.elsevier.com/permissions). 
If excerpts from other copyrighted works are included, the author(s) must obtain written permission 
from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use 
by authors in these cases: please consult http://www.elsevier.com/permissions. 
Elsevier supports responsible sharing 
Find out how you can share your research published in Elsevier journals. 
Preparation of electronic illustrations When submitting via the online system, authors are required to 
provide electronic versions of their illustrations. When an article has been accepted, authors must be 
prepared to provide all illustrations in electronic and camera-ready format. Information relating to the 
preferred formats for artwork may be found at http://www.elsevier.com/authors and also on the online 
submission homepage http://ees.elsevier.com/jinj/. 
Submitting your artwork in an electronic format helps us to produce your work to the best possible 
standards, ensuring accuracy, clarity and a high level of detail. 
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* Make sure that you use uniform lettering and sizing in the original artwork. 
* Save text in illustrations as "graphics", or enclose the font. 
* Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol. 
* Number the illustrations according to their sequence in the text. 
* Use a logical naming convention for your artwork files, supplying a separate listing of the files. 
* Provide all illustrations as separate files and as hardcopy printouts on separate sheets. 
* Provide captions to illustrations separately. 
* Produce images near to the desired size of the printed version. * ZIP-disk or CDs may be used. 
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artworkinstructions 
Author enquiries 
For enquiries relating to the submission of articles (including electronic submission where available) 
please visit this journal's homepage at http://www.elsevier.com/locate/injury. You can track accepted 
articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an 
article’s status has changed. Also accessible from here is information on copyright, frequently asked 
questions and more. 
Contact details for questions arising after acceptance of an article, especially those relating to proofs, 
will be provided by the publisher. 
Illustration services 
Elsevier's Web Shop (http://webshop.elsevier.com/illustrationservices) offers Illustration Services to 
authors preparing to submit a manuscript but concerned about the quality of the images accompanying 
their article. Elsevier's expert illustrators can produce scientific, technical and medical-style images, as 
well as a full range of charts, tables and graphs. Image 'polishing' is also available, where our illustrators 
take your image(s) and improve them to a professional standard. Please visit the website to find out 
more. 
Colour Reproduction 
Submit colour illustrations via the online submission system. If, together with your accepted article, you 
submit usable colour figures, then Elsevier will ensure, at no additional charge, that these figures will 
appear in colour on the web (e.g., ScienceDirect and other sites), regardless of whether or not these 
illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will 
receive information from Elsevier regarding the costs, after receipt of your accepted article. 
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Please note: Because of technical complications which can arise by converting colour figures to 'grey 
scale' (for the printed version, should you not opt for colour in print) please submit additionally usable 
black and white prints corresponding to all the colour illustrations. 
Supplementary data 
We accept supplementary electronic material to support and enhance the paper. Supplementary files 
offer additional possibilities to publish supporting applications, animation sequences, high-resolution 
images, background datasets, sound clips and more. These will be published online, alongside the 
electronic version of your article in Elsevier web products, including ScienceDirect: 
http://www.sciencedirect.com/. Please ensure that data is provided in one of our recommended file 
formats. Authors should submit the material in electronic format, together with the article, and supply a 
concise and descriptive caption for each file. For more detailed instructions please go to 
http://www.elsevier.com/authors. 
RESEARCH DATA 
This journal encourages and enables you to share data that supports your research publication where 
appropriate, and enables you to interlink the data with your published articles. Research data refers to 
the results of observations or experimentation that validate research findings. To facilitate 
reproducibility and data reuse, this journal also encourages you to share your software, code, models, 
algorithms, protocols, methods and other useful materials related to the project.  
Below are a number of ways in which you can associate data with your article or make a statement 
about the availability of your data when submitting your manuscript. If you are sharing data in one of 
these ways, you are encouraged to cite the data in your manuscript and reference list. Please refer to 
the "References" section for more information about data citation. For more information on depositing, 
sharing and using research data and other relevant research materials, visit the research data page. 
Data linking  
If you have made your research data available in a data repository, you can link your article directly to 
the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with 
relevant repositories, giving readers access to underlying data that gives them a better understanding of 
the research described.  
There are different ways to link your datasets to your article.  
When available, you can directly link your dataset to your article by providing the relevant information 
in the submission system. For more information, visit the database linking page. For supported data 
repositories a repository banner will automatically appear next to your published article on 
ScienceDirect. 
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In addition, you can link to relevant data or entities through identifiers within the text of your 
manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 
1XFN).  
Mendeley Data  
This journal supports Mendeley Data, enabling you to deposit any research data (including raw and 
processed data, video, code, software, algorithms, protocols, and methods) associated with your 
manuscript in a free-to-use, open access repository. During the submission process, after uploading your 
manuscript, you will have the opportunity to upload your relevant datasets directly to Mendeley Data. 
The datasets will be listed and directly accessible to readers next to your published article online.  
For more information, visit the Mendeley Data for journals page. 
Data statement  
To foster transparency, we encourage you to state the availability of your data in your submission. This 
may be a requirement of your funding body or institution. 
If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why 
during the submission process, for example by stating that the research data is confidential. The 
statement will appear with your published article on ScienceDirect. For more information, visit the Data 
statement page. 
Use of the Digital Object Identifier (DOI)  
The digital object identifier (DOI) may be used to cite and link to electronic documents. The DOI consists 
of a unique alpha-numeric character string which is assigned to a document by the publisher upon the 
initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing 
a document, particularly 'Articles in press' because they have not yet received their full bibliographic 
information. 
The correct format for citing a DOI is shown as follows (example taken from a document in the journal 
Physics Letters B): 
doi: 10.1016/j.physletb.2003.10.071 
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to 
change. 
Types of submission 
1. Full length articles. 
Original, full-length, research papers, which have not been published previously, except in a preliminary 
form, may be submitted as regular papers. 
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2. Case Reports. 
The Editors recommend submitting case reports to the open access journal, Trauma Case Reports, which 
has the same editorial team as Injury (accepted authors will be charged a fee). To submit a case report 
to Trauma Case Reports, please go to http://ees.elsevier.com/tcr/  
3. Letters to the Editor. 
Letters to the Editor are encouraged, particularly those that comment on an article previously published 
in the journal. These should be submitted via the online submission system. 
Submissions 
Authors are requested to submit their original manuscript and figures online, via 
http://ees.elsevier.com/jinj/ Full instructions are located on this site. 
If you have any problems submitting your paper through this system, please contact the Editorial Office 
on: e-mail: injury@elsevier.com. 
A PDF proof is generated from the uploaded files and this is then sent to at least two reviewers. All 
correspondence, including notification of the Editor's decision and requests for revisions, will be 
managed via this system. 
If you do not receive any response within 8 weeks after the acknowledgement that your paper has been 
successfully uploaded, you may contact the Editorial Office, preferably by e-mail (injury@elsevier.com). 
Authors may also track the progress of their paper using this system to final decision. 
Your manuscript should be submitted together with a covering letter which should be signed by the 
corresponding author on behalf of all authors and should include: 
* A statement that all authors have made substantial contributions to all of the following: (1) the 
conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) 
drafting the article or revising it critically for important intellectual content, (3) final approval of the 
version to be submitted. All contributors who do not meet the criteria for authorship as defined above 
should be listed in an acknowledgements section. Examples of those who might be acknowledged 
include a person who provided purely technical help, writing assistance, or is the chair of the 
department who provided only general support. Authors should disclose whether they had any writing 
assistance and identify the source of payment for this assistance. 
* A statement that the manuscript, including related data, figures and tables has not been previously 
published and is not under consideration elsewhere. 
* The names and contact addresses (including e-mail) of 2 potential reviewers that have not been 
involved in the design, performance and discussion of the data and are not a co-worker. These may or 
may not be used at the Editor's discretion. You may also mention persons who you would prefer not to 
review your paper. 
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Conflict of Interest All authors must disclose any financial and personal relationships with other people 
or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of 
interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent 
applications/registrations, and grants or other funding. The Conflict of Interest statement should be 
uploaded as a separate file. 
Role of the funding source All sources of funding should be acknowledged at the end of the text. 
Authors should declare any involvement of study sponsors in the study design; collection, analysis and 
interpretation of data; the writing of the manuscript; the decision to submit the manuscript for 
publication. If the study sponsors had no such involvement, this should be stated. Please see 
http://www.elsevier.com/funding 
Randomised controlled trials All randomised controlled trials submitted for publication in Injury should 
include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to 
the CONSORT statement website at http://www.consort-statement.org for more information. 
Ethics Work on human beings that is submitted to Injury should comply with the principles laid down in 
the Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving 
human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended 
by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, 
Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The 
manuscript should contain a statement that the work has been approved by the appropriate ethical 
committees related to the institution(s) in which it was performed and that subjects gave informed 
consent to the work. Studies involving experiments with animals must state that their care was in 
accordance with institution guidelines. Patients' and volunteers' names, initials, and hospital numbers 
should not be used. The statement should be uploaded as a separate file. 
Authors' rights 
As an author you (or your employer or institution) retain certain rights; for details you are referred to: 
http://www.elsevier.com/copyright. 
Revisions should be completed and resubmitted within 3 months, and the changes made should be 
highlighted or listed in the resubmitted article. 
Upon acceptance of an article, an e-mail (or letter) will be sent to the corresponding author confirming 
receipt of the manuscript together with a 'Journal Publishing Agreement' form which the authors will be 
asked to sign (for more information see http://www.elsevier.com/authors). 
The Editor reserves the right to make editorial and literary corrections. No major alterations, or 
corrections, will be made without the knowledge and consent of the authors. 
Proofs. 
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After final acceptance, one set of page proofs in PDF format will be sent by e-mail to the corresponding 
author (if we do not have an e-mail address then paper proofs will be sent by post). Elsevier now sends 
PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 
available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to 
annotate PDF files will accompany the proofs. System requirements are given at the Adobe site: 
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win. 
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to 
the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If 
this is not possible, then mark the corrections and any other comments (including replies to the Query 
Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. 
Please use this proof only for checking the typesetting, editing, completeness and correctness of the 
text, tables and figures. Significant changes to the article as accepted for publication will only be 
considered at this stage with permission from the Editor. We will do everything possible to get your 
article published quickly and accurately. Therefore, it is important to ensure that all of your corrections 
are sent back to us in one communication: please check carefully before replying, as inclusion of any 
subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that 
Elsevier may proceed with the publication of your article if no response is received. 
Offprints 
The corresponding author will be provided with a free PDF file of the article via e-mail. The PDF file is a 
watermarked version of the published article and includes a cover sheet with the journal cover image 
and a disclaimer outlining the terms and conditions of use. Paper offprints can be ordered by the 
authors. An order form with prices will be sent to the corresponding author. 
Audio Slides 
The journal encourages authors to create an Audio Slides presentation with their published article. 
Audio Slides are brief, webinar-style presentations that are shown next to the online article on 
ScienceDirect. This gives authors the opportunity to summarize their research in their own words and to 
help readers understand what the paper is about. More information and examples are available at 
http://www.elsevier.com/audioslides. Authors of this journal will automatically receive an invitation e-
mail to create an Audio Slides presentation after acceptance of their paper.  
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Included hospital and provincial approvals as well as the BREC approval (or waiver if appropriate). 
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